Michael Weintraub

CMS announced a new innovation model targeting chronic conditions. Released today by CMS - The ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model tests an outcome-aligned payment approach in Original Medicare to expand access to new technology-supported care options that help people improve their health and prevent and manage chronic disease. This 10-year model will focus on paying providers for actual outcomes versus activities. It's centered on the use of technology and given the 10-year horizon I can see this quickly evolving into an AI driven model where PCP's provide oversight but enable Medicare patients to manage their conditions through AI driven technology provided to the patient and tracked by their PCP. It's a voluntary model so it will be interesting to see the adoption. July 1, 2026 is the start date which seems aggressive. Find more here: https://lnkd.in/gR5Hg3p7

6

Rock Health H1 2025 Market Overview: Signals of Maturity The latest market scan from Rock Health is more than a funding recap—it’s a validation of digital health’s evolution from experimentation to execution. H1 2025 Market Overview: Proof in the Pudding Capital is consolidating around performance. With $6.4B deployed across fewer deals, investors are making bigger bets on platforms that show real-world traction. AI-enabled startups raised 62% of all funding, commanding an 83% premium over non-AI peers. This isn’t just hype—it’s a shift in how value is being priced.  Provider workflow is the new infrastructure. Clinical and non-clinical workflow solutions drew 55% of total funding. That’s a clear signal: the market is rewarding tools that drive measurable ROI and integrate seamlessly into care delivery. Exits are back—and they’re meaningful. Hinge Health and Omada Health’s IPOs show that tech-enabled care delivery can scale sustainably. Their decade-long journey to evidence-based, AI-augmented models is a blueprint for what’s possible when product, outcomes, and trust align. Ambient documentation and medical reference tools are scaling faster than any tech in healthcare history. Abridge and OpenEvidence are proving that provider trust, intuitive UX, and capital efficiency can unlock breakout growth. These aren’t pilots—they’re platforms. This report reinforces: → Scalable impact requires trust, usability, and validated outcomes. https://lnkd.in/gVhtgK5e Would love to hear how others are interpreting this moment. What’s your capital allocation thesis in H2? #DigitalHealth #HealthTechInvesting #AIinHealthcare #CareNavigation #ReferWell #HealthTechStrategy #VentureCapital #HealthcareInnovation

27

1 Comment